The weekly litigation news digest is live. Subscribe now

Methods For Treating Hypertrophic Cardiomyopathy - EP4370116

The patent EP4370116 was granted to Cytokinetics on Jan 15, 2025. The application was originally filed on Jul 15, 2022 under application number EP22753953A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4370116

CYTOKINETICS
Application Number
EP22753953A
Filing Date
Jul 15, 2022
Status
Granted And Under Opposition
Dec 13, 2024
Publication Date
Jan 15, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HAMM & WITTKOPPOct 14, 2025HAMM & WITTKOPPADMISSIBLE
SYNTHONOct 14, 2025HAMM & WITTKOPPADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2019144041
DESCRIPTIONWO2021011807
DESCRIPTIONWO2021011808
INTERNATIONAL-SEARCH-REPORTWO2019144041
INTERNATIONAL-SEARCH-REPORTWO2021011807
INTERNATIONAL-SEARCH-REPORTWO2021011808
OPPOSITIONWO2021011808

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents